<div class="headers"><div>Figure 2. Ischemic and bleeding outcomes by randomized treatment arm, according to diabetes mellitus status. Treatment effect according to diabetes status at 12 to 30 months, in all randomly assigned patients (n=11 648) for the outcomes of stent thrombosis, major adverse cardiovascular and cerebrovascular events, and severe or moderate bleeding </div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">Figure 2. Ischemic and bleeding outcomes by randomized treatment arm, according to diabetes mellitus status. Treatment effect according to diabetes status at 12 to 30 months, in all randomly assigned patients (n=11 648) for the outcomes of stent thrombosis, major adverse cardiovascular and cerebrovascular events, and severe or moderate bleeding </p></td>
</tr>
</tbody>
</table>
